Skip to main content
. 2022 Apr 18;10(4):631. doi: 10.3390/vaccines10040631

Figure 1.

Figure 1

Characteristics of SVV LNSYO1-2017. (A) The cytopathic effect of BHK-21 cells infected with SVV LNSYO1-2017 strain at 24 h post-infection. (B) Plaque morphology in BHK-21 cells infected with third-passage of SVV LNSYO1-2017 strain at 48 h post-infection. (C) Immunofluorescence assay (IFA) of BHK-21 cells infected with SVV LNSYO1-2017 strain at 18 h post-infection. Cells were stained with primary antibody using homemade rabbit anti-SVV VP1 polyclonal antibody. (D) Western blotting analyses of BHK-21 cells infected with SVV LNSYO1-2017 strain at 18 h post-infection. Cells were stained with primary antibody using a homemade rabbit polyclonal anti-SVV VP1 antibody and mouse anti-tubulin antibody.